METHYL (2S,4S)-4-(4-CHLORO-3-METHYLPHENOXY)-2-PYRROLIDINECARBOXYLATE
- $205 - $412.65
- Product name: METHYL (2S,4S)-4-(4-CHLORO-3-METHYLPHENOXY)-2-PYRROLIDINECARBOXYLATE
- CAS: 1217844-23-9
- MF: C13H16ClNO3
- MW: 269.72
- EINECS:
- MDL Number:MFCD08688211
- Synonyms:METHYL (2S,4S)-4-(4-CHLORO-3-METHYLPHENOXY)-2-PYRROLIDINECARBOXYLATE;D-Proline, 4-(4-chloro-3-methylphenoxy)-, methyl ester, (R,4R)-rel-
3 prices
Selected condition:
Brand
- American Custom Chemicals Corporation
- Matrix Scientific
- Sigma-Aldrich
Package
- 500MG
- ManufacturerAmerican Custom Chemicals Corporation
- Product numberCCH0001038
- Product descriptionMETHYL (2S,4S)-4-(4-CHLORO-3-METHYLPHENOXY)-2-PYRROLIDINECARBOXYLATE 95.00%
- Packaging500MG
- Price$412.65
- Updated2021-12-16
- Buy
- ManufacturerMatrix Scientific
- Product number023661
- Product descriptionMethyl (2S,4S)-4-(4-chloro-3-methylphenoxy)-2-pyrrolidinecarboxylate
- Packaging500mg
- Price$205
- Updated2021-12-16
- Buy
- ManufacturerSigma-Aldrich
- Product numberPH017960
- Product descriptionMethyl (2S,4S)-4-(4-chloro-3-methylphenoxy)-2-pyrrolidinecarboxylate AldrichCPR
- Packaging500mg
- Price$241
- Updated2023-06-20
- Buy
Manufacturer | Product number | Product description | Packaging | Price | Updated | Buy |
---|---|---|---|---|---|---|
American Custom Chemicals Corporation | CCH0001038 | METHYL (2S,4S)-4-(4-CHLORO-3-METHYLPHENOXY)-2-PYRROLIDINECARBOXYLATE 95.00% | 500MG | $412.65 | 2021-12-16 | Buy |
Matrix Scientific | 023661 | Methyl (2S,4S)-4-(4-chloro-3-methylphenoxy)-2-pyrrolidinecarboxylate | 500mg | $205 | 2021-12-16 | Buy |
Sigma-Aldrich | PH017960 | Methyl (2S,4S)-4-(4-chloro-3-methylphenoxy)-2-pyrrolidinecarboxylate AldrichCPR | 500mg | $241 | 2023-06-20 | Buy |
Properties
Boiling point :374.8±42.0 °C(Predicted)
Density :1.225±0.06 g/cm3(Predicted)
pka :6.96±0.10(Predicted)
Density :1.225±0.06 g/cm3(Predicted)
pka :6.96±0.10(Predicted)
Safety Information
Symbol(GHS): | ||||||||
---|---|---|---|---|---|---|---|---|
Signal word: | ||||||||
Hazard statements: |
|
|||||||
Precautionary statements: |
|